Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAA: Prophylactic Anticoagulation in CKD Patients with Lower Limb Fracture
NCT06795698Phase 2Completed
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Mar 2019
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Hospital Civil de Guadalajara. Primary endpoint: Major bleeding events. Started Mar 2019; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT06795698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06795698.